Findings from Australian oncology early career professionals

https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/d0/19/e7/d019e72f-05f2-8d1d-bd8e-a211c71aae72/mza_14299790810783861641.jpg/600x600bb.jpg

NECTA Annual Drug Development Meeting

NECTA

7 episodes

1 week ago

Each year the NSW Early Phase Clinical Trials Alliance (NECTA) hosts the international Drug Development Meeting. Join us in listening to world-renowned speakers dive into topics across oncological therapy development, from trial design to the emerging use of AI.

Medicine

Health & Fitness

RSS

All content for NECTA Annual Drug Development Meeting is the property of NECTA and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medicine

Health & Fitness

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_nologo/40933329/40933329-1712547350131-8c00bb869ff44.jpg

Findings from Australian oncology early career professionals

NECTA Annual Drug Development Meeting

1 hour 10 minutes 48 seconds

1 year ago

Findings from Australian oncology early career professionals

Dr Jenny Liu, St Vincent’s Hospital Sydney - Benefits of liquid biopsy with an early phase trial referral network Dr Abhijit Pal, Liverpool Hospital - Informed consent for early phase cancer clinical trials – common pitfalls and pragmatic solutions Dr Christina Teng, Scientia Clinical Research - Case Study: the impact of trial participation on the individual patient Session 1, Section 2